Latest News

MMS Holdings Recognized as one of the UK’s Best Workplaces in BioPharma™

Belfast, Northern Ireland, and Canton, Michigan – The 2026 UK’s Best Workplaces in BioPharma™ list was launched in September by Great Place To Work® UK, with MMS Holdings (MMS) recognized in the Small & Medium category.

MMS prioritizes flexible working, giving employees the autonomy to manage their work while delivering exceptional results. Built on trust, accountability, and open communication, this approach helps employees feel respected, supported, and empowered to perform at their best.

MMS’ global reward and recognition platform helps leaders and colleagues celebrate achievements and stay connected. Quarterly SOUL (Sense of Urgency and Leadership) Awards honor employees worldwide who live the company’s values and make a meaningful impact on clients, colleagues, and the business. Alongside long service and ad hoc awards, this recognition builds pride and reinforces each employee’s role in MMS’ shared success.

As a global organization, MMS balances flexible working with opportunities for meaningful connection. Social events, client accolades, team gatherings, and personal celebrations bring colleagues together, strengthening relationships, collaboration, and MMS’ strong sense of community.

MMS recognizes that wellbeing needs vary across life stages. In the UK, the company has enhanced family-friendly benefits, including additional paternity leave and flexible return-to-work arrangements for new parents. MMS also provides a market-leading Employee Assistance Program and wider wellbeing support, to help employees thrive personally and professionally.

Great Place To Work® UK determined the Best Workplaces™ list using its research-backed Trust Index™ employee survey of UK-based BioPharma employees. The survey asked employees to assess how their company supports work-life balance, fulfilment, job satisfaction, psychological safety, and financial security. Evaluations also considered how consistently organizations deliver a positive employee experience across departments and seniority levels.

Andy Hunt, Associate Director of UK HR, MMS, said: “MMS is a place where people work hard, support one another, and celebrate shared success. This recognition is especially meaningful because it reflects our people’s voices and the culture we continue to build together.

Over recent years, MMS has grown significantly, including through the 2025 acquisition of Exploristics, a specialist Belfast-based biostatistics organization. Throughout this period of change, our people have shown flexibility, collaboration, and commitment to our values. This recognition helps to make MMS a great place to work.”

Benedict Gautrey, Managing Director of Great Place To Work® UK, said: 

“The BioPharma sector is experiencing significant change as organizations embrace digital innovation, including the growing role of AI, while navigating the impact this has on their people and ways of working. The UK’s Best Workplaces in BioPharma™ list demonstrates that it is possible to drive transformation while maintaining a strong focus on employee experience. These organizations create cultures where people have clarity, opportunities to develop, and the flexibility to do their best work. Through trusted leadership, open communication, and inclusive approaches to decision-making, they help employees feel supported, confident, and ready to embrace the future. Congratulations to MMS on being recognized as a UK’s Best Workplace in BioPharma™ and for creating a workplace where people can thrive through change.”

About MMS Holdings

MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) supporting pharmaceutical and biotechnology companies with a proven scientific approach to complex clinical trial data and regulatory submission challenges. MMS delivers measurable value through deep regulatory expertise, advanced analytics, and a commitment to quality across the development lifecycle.

For more information, visit www.mmsholdings.com

About Great Place To Work®

Great Place To Work® is the global authority on workplace culture, on a mission to make every company a great workplace for all. Every year, they receive direct feedback from over 10 million workers around the world telling them how they really feel about their employer. Their survey is completely confidential and anonymous, so people can feel comfortable to be honest about their workplace, and companies can gain detailed insights into how they can better serve their people.

Only those employers who have the highest levels of trust, job satisfaction, and who empower ALL their employees to thrive both in and outside of work are awarded official Best Workplaces™ recognition.

For more information, visit www.greatplacetowork.co.uk

Media Contact

Caitlin Magee

Caimag01@mmsholdings.com

Suggested For You

news

September 29th, 2026

MMS Shortlisted for Best CRO - Specialist Provider by the 2026 Scrip Awards

news

June 8th, 2026

MMS Highlights Expanded West Coast Biotech Engagement Ahead of BIO International Convention 2026

news

May 12th, 2026

MMS Strengthens Science-Led Global Leadership, Naming Ben Dudley as President 

news

February 5th, 2026

MMS Appoints FDA Alum Dr. Somya Dunn as Senior Medical Director, Safety Risk Management to Expand Leadership in REMS and Pharmacovigilance Solutions 

news

January 29th, 2026

Datacise® by MMS Named Finalist for Innovation in the Management of Clinical Data at the 2026 ACDM Awards 

news

December 4th, 2025

Former FDA, CRO, and Industry Leader Dr. Stephine Keeton Joins MMS as Senior Director of Biometrics 

news

November 14th, 2025

MMS Brings Biometrics and AI Leadership to PHUSE EU Connect 2025 and Previews Accepted Presentations for US Connect 2026

news

October 16th, 2025

MMS Named Finalist in the Fierce Life Sciences Innovation Awards for KerusCloud® Clinical Trial Simulation Platform 

news

October 2nd, 2025

MMS Announces Its Role in Supporting Gates Ventures and the GNPC to Deliver One of the World's Largest Proteomic Datasets for Neurodegenerative Diseases

news

September 24th, 2025

MMS Named Finalist in Citeline’s 2025 Scrip Awards for Best Contract Research Organization (CRO) – Specialist Providers 

news

August 19th, 2025

Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials

news

June 19th, 2025

MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and Dr. Uma Sharma Named CRO Champion